Revolutionizing Clinical Trials with TrialKey: An AI-Powered Solution with Michelle Gallaher and Damon Rasheed

Join us as we delve into the world of TrialKey, a cutting-edge technology developed by Opin, with its CEO Michelle Gallaher and Head of Technology Damon Rasheed. Discover how this solution is predicting the success of clinical trials with machine learning and advanced AI, and the impact it is having on the drug development industry. Tune in to learn how you can stay ahead of the curve.